Form 4 Filing for Apogee Therapeutics, Inc. - Insider Transaction

This filing details a Form 4 submission for Apogee Therapeutics, Inc. (APGE) concerning transactions made by Jane Henderson, the Chief Financial Officer. On April 1, 2026, Ms. Henderson executed a sale of 900 shares of Common Stock at a weighted average price of $84.46 per share, with individual transactions ranging from $84.15 to $85.05. Following this transaction, her post-transaction shares totaled 178,471. Additionally, on the same date, she sold 1,100 shares of Common Stock at a weighted average price of $85.46 per share, with prices ranging from $85.17 to $85.79. This resulted in 177,371 shares remaining in her possession. These transactions were conducted under a Rule 10b5-1 trading plan adopted on September 2, 2025. The filing was signed by Matthew Batters as attorney-in-fact for Jane Pritchett Henderson on April 3, 2026.